The AI Times
All desks
Read another desk
All Geopolitics & international affairsEconomyUnited StatesAnglosphereEuropeRussia & EurasiaLevant & Iran Gulf & Türkiye North Africa Africa South Asia East Asia Latin America Energy Technology Media Watch
Sections
News Panel Outlets Headlines Analysis & editorial coming soon
Who we are Alerts Pricing Sign in / up
Desks
All Geopolitics & international affairsEconomyUnited StatesAnglosphereEuropeRussia & EurasiaLevant & Iran Gulf & Türkiye North Africa Africa South Asia East Asia Latin America Energy Technology Media Watch
The AI Times
every claim sourced| every source shown| always on watch

Amer Solyman

Byline seen at Anadolu Agency.

person
6 reports under this byline 1 outlet 0 bias readings 0 claims checked 8 Sep 2026 → 28 Oct 2026

Roles

OutletRoleFromToSource
Anadolu Agency
State / loyalist estimate · not a score
Anadolu Agency 🇹🇷TR · state agency · state-controlled No report held from this outlet on this story. What we have measured Actor named Names five governments as the ones that suspended flights, and ties it to US sanctions ×1Asserted vs expected the agenda is given as an expectation, not an outcome ×1Assertion vs attribution Credits the continuing investigation to the FDA by name ×1Attributed or stated the adviser's judgement on rates is stated as sight, not as a claim he made ×1 from 6606 articles we hold · quote attached Outlet profile in The AI Times →
byline—present —

Bias we have measured on this byline

Nothing scored on this byline yet.
From 6 reports we hold under this byline, at Anadolu Agency. Two independent readings, each made without the masthead, with the quote attached to every tag. We do not carry a rating for any journalist — only what we have measured from published text, and a verdict on a claim is a verdict on that sentence, not on the person who filed it.

Headlines they wrote

Sign in to The AI Times

Everything is free while we are building it. Signing in is how comments, likes and your reading stay yours.

Continue with Google

Sign-in is coming soon.

By continuing you agree to be a reader of a paper that shows its working.

×